Zavedos 10 mg Norvēģija - norvēģu - Statens legemiddelverk

zavedos 10 mg

pfizer as - idarubicinhydroklorid - pulver til injeksjonsvæske, oppløsning - 10 mg

Zavedos 5 mg Norvēģija - norvēģu - Statens legemiddelverk

zavedos 5 mg

pfizer as - idarubicinhydroklorid - pulver til injeksjonsvæske, oppløsning - 5 mg

Sandimmun Neoral 25 mg Norvēģija - norvēģu - Statens legemiddelverk

sandimmun neoral 25 mg

novartis norge (2) - ciklosporin - kapsel, myk - 25 mg

Sandimmun Neoral 50 mg Norvēģija - norvēģu - Statens legemiddelverk

sandimmun neoral 50 mg

novartis norge (2) - ciklosporin - kapsel, myk - 50 mg

Sandimmun Neoral 100 mg Norvēģija - norvēģu - Statens legemiddelverk

sandimmun neoral 100 mg

novartis norge (2) - ciklosporin - kapsel, myk - 100 mg

Sandimmun Neoral 100 mg/ ml Norvēģija - norvēģu - Statens legemiddelverk

sandimmun neoral 100 mg/ ml

novartis norge (2) - ciklosporin - mikstur, oppløsning - 100 mg/ ml

Incruse Ellipta (previously Incruse) Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

incruse ellipta (previously incruse)

glaxosmithkline (ireland) limited - umeclidiniumbromid - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - indikeres som en vedlikeholdsbronkodilatorbehandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kol).

Drovelis Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - sex hormoner og modulatorer av genital systemet, - oral contraceptive.

Lydisilka Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

lydisilka

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - sex hormoner og modulatorer av genital systemet, - oral prevensjon. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.